Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

A number of viral vectors are currently being evaluated as potential gene therapy vectors for gene delivery to the brain. As well as evaluating their ability to express a transgene for extended periods of time it is also essential to examine any cytotoxic immune response to such vectors as this may not only limit transgene expression but also cause irreparable harm. This work describes the effect of inoculating a gamma34.5 mutant of herpes simplex type 1 (1716lacZ) into the brain of different strains of rats and mice. Animals were monitored for weight loss and signs of illness, and their brains were evaluated for inflammation, beta-galactosidase expression and recoverable infectious virus. We report that there is (i) a powerful immune response consisting of an early non-specific phase and a later presumably T-cell-mediated phase; (ii) significant weight loss in some animals strains accompanied by severe signs of clinical illness and (iii) transient reporter gene expression in all animal strains examined. To be useful for gene therapy we suggest this virus requires further modification, it should be tested in several animal strains and the dose of virus used may be critical in order to limit damage.

Type

Journal article

Journal

Neuroscience

Publication Date

04/1998

Volume

83

Pages

1225 - 1237

Keywords

Animals, Antigens, Viral, Brain, Caudate Nucleus, Cell Line, Cricetinae, Genes, Reporter, Genetic Therapy, Genetic Vectors, Herpesvirus 1, Human, Histocompatibility Antigens Class I, Histocompatibility Antigens Class II, Inflammation, Mice, Mice, Inbred BALB C, Mice, Inbred C3H, Rats, Rats, Inbred Strains, Species Specificity, Virulence, Virus Replication, Weight Loss, beta-Galactosidase